Cargando…

Hydroxychloroquine + azithromycin treatment in elderly patients

Detalles Bibliográficos
Autores principales:	Gautret, Philippe, Ly, Tran Duc Anh, Raoult, Didier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd and International Society of Antimicrobial Chemotherapy. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948678/ https://www.ncbi.nlm.nih.gov/pubmed/33716178 http://dx.doi.org/10.1016/j.ijantimicag.2021.106313

Ejemplares similares

Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients
por: Gautret, Philippe, et al.
Publicado: (2021)

Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19
por: Gautret, Philippe, et al.
Publicado: (2021)

Effect of hydroxychloroquine and azithromycin on the viral clearance of SARS-CoV-2: response to Hervé Seligmann
por: Gautret, Philippe, et al.
Publicado: (2021)

Effect of hydroxychloroquine and azithromycin on SARS-CoV-2 clearance in COVID-19 patients, a meta-analysis.
por: Million, Matthieu, et al.
Publicado: (2021)

Response to uncertain effect of hydroxychloroquine and azithromycin on SARS-CoV-2 viral load.
por: Gautret, Philippe, et al.
Publicado: (2021)

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited
por: Gautret, Philippe, et al.
Publicado: (2021)

Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.
por: Gautret, Philippe, et al.
Publicado: (2021)

Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes
por: Gautret, Philippe, et al.
Publicado: (2021)

Re: ‘Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients’ by Fiolet et al.
por: Million, Matthieu, et al.
Publicado: (2021)

Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin
por: Million, Matthieu, et al.
Publicado: (2021)

Response to effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial.
por: Gautret, Philippe, et al.
Publicado: (2021)

Timing and dosage may be the key in the realisation of hydroxychloroquine + azithromycin treatment benefit in Covid-19 elderly patients
por: Lacout, Alexis, et al.
Publicado: (2021)

Combination of Hydroxychloroquine Plus Azithromycin As Potential Treatment for COVID-19 Patients: Safety Profile, Drug Interactions, and Management of Toxicity
por: Hache, Guillaume, et al.
Publicado: (2021)

Problems with the analysis in “Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19”
por: Atkinson, J. Graham
Publicado: (2020)

Reply to Alizazgar J. Dangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients
por: Honoré, Stéphane, et al.
Publicado: (2021)

Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: authors' response
por: Fiolet, Thibault, et al.
Publicado: (2021)

Use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature
por: Goldman, Jason D., et al.
Publicado: (2021)

Uncertain effects of hydroxychloroquine and azithromycin on SARS-Cov-2 viral load
por: Nguyen, Tuan V.
Publicado: (2021)

Outcomes after early treatment with hydroxychloroquine and azithromycin: An analysis of a database of 30,423 COVID-19 patients
por: Brouqui, Philippe, et al.
Publicado: (2023)

Re: effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: author's response
por: Fiolet, Thibault, et al.
Publicado: (2021)

Experience of short-term hydroxychloroquine and azithromycin in COVID-19 patients and effect on QTc trend
por: Hor, Chee Peng, et al.
Publicado: (2020)

Doxycycline as an Alternative to Azithromycin in Elderly Patients
por: Malek, Alexandre Elias, et al.
Publicado: (2021)

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
por: Gautret, Philippe, et al.
Publicado: (2020)

Re: ‘Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients’ by Fiolet et al.
por: Lacout, Alexis, et al.
Publicado: (2021)

Preliminary Feasibility Study of Questionnaire-based Active Pulmonary Tuberculosis Screening in Marseille Sheltered Homeless People, Winter 2018
por: Ly, Tran Duc Anh, et al.
Publicado: (2019)

Pro-apoptotic effect of doxycycline and hydroxychloroquine on B-cell lymphoma induced by C. burnetii
por: Melenotte, Cléa, et al.
Publicado: (2017)

SARS-CoV-2 Persistent Viral Shedding in the Context of Hydroxychloroquine-Azithromycin Treatment
por: Drancourt, Michel, et al.
Publicado: (2021)

Screening for SARS-CoV-2 antibodies to save vaccine doses
por: Fenollar, Florence, et al.
Publicado: (2022)

Referring to the study: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial
por: dos Santos, Marcelo Rodrigues
Publicado: (2021)

No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
por: Molina, J.M., et al.
Publicado: (2020)

Letter to the editor about “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial”
por: Saad, Mohamed O
Publicado: (2021)

Focus on clinical outcomes of “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial”
por: Wambier, Carlos Gustavo
Publicado: (2021)

Response to advances statistical methods and designs for clinical trials for COVID-19
por: Gautret, Philippe, et al.
Publicado: (2021)

Long-term persistence of olfactory and gustatory disorders in COVID-19 patients
por: Nguyen, Nhu Ngoc, et al.
Publicado: (2021)

Response to the editorial “COVID-19 in patients with cardiovascular diseases”: Covid-19 treatment with hydroxychloroquine or chloroquine and azithromycin: A potential risk of Torsades de Pointes
por: Funck-Brentano, Christian, et al.
Publicado: (2020)

Interpretation of SARS-CoV-2 PCR results for the diagnosis of COVID-19
por: Colson, Philippe, et al.
Publicado: (2021)

Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France
por: Million, Matthieu, et al.
Publicado: (2020)

Re: Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: a systematic review and meta-analysis' by Fiolet et al.
por: Vedrines, Nicolas, et al.
Publicado: (2021)

Inpatient Use of Ambulatory Telemetry Monitors for COVID-19 Patients Treated With Hydroxychloroquine and/or Azithromycin
por: Chang, David, et al.
Publicado: (2020)

Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis
por: Lagier, Jean-Christophe, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_chrhg5l57ncscvmpdvpdg1lp4q